Cytosorbents (CTSO) Shares Outstanding (Entity) (2010 - 2026)
Cytosorbents (CTSO) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 1.73 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 383.57 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 576.60 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 377.40 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 451.69 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 977.43 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 97.50 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | 62.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.84 Mn |
| Mar 31, 2026 | 62.73 Mn |
| Dec 31, 2025 | 62.80 Mn |
| Sep 30, 2025 | 62.79 Mn |
| Jun 30, 2025 | 62.61 Mn |
| Mar 31, 2025 | 62.53 Mn |
| Dec 31, 2024 | 54.83 Mn |
| Sep 30, 2024 | 54.50 Mn |
| Jun 30, 2024 | 54.31 Mn |
| Mar 31, 2024 | 54.29 Mn |
| Dec 31, 2023 | 44.66 Mn |
| Sep 30, 2023 | 44.44 Mn |
| Jun 30, 2023 | 44.19 Mn |
| Mar 31, 2023 | 43.85 Mn |
| Dec 31, 2022 | 43.64 Mn |
| Sep 30, 2022 | 43.63 Mn |
| Jun 30, 2022 | 43.57 Mn |
| Mar 31, 2022 | 43.51 Mn |
| Dec 31, 2021 | 43.48 Mn |
| Sep 30, 2021 | 43.48 Mn |